Skip to main content
Caplight Logo









NK:IO

NK:IO

Private
LondonHealthcare & Life Scienceshttps://nk-io.com/

Last Round

Seed

Oct 23, 2024

Total Funding Raised

$7.4M

Company Overview

NK:IO is a biotechnology company developing off-the-shelf natural killer (NK) cell therapies for the treatment of solid tumours.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

NK cell therapyoff-the-shelf cell therapyallogeneic cell therapycancer immunotherapycell therapy platformengineered NK cellssolid tumourscell and gene therapyCGTumbilical cord bloodsmall molecule therapyin vivo cell productionovarian cancerpreclinical biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NK:IO Comparables

Compare NK:IO with similar companies based on industry and business-model similarity.

NK:IO comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CytoImmune Therapeutics
84%
ONK Therapeutics
82%
Shanghai Enkai Cell Technology Co., Ltd.
81%

NK:IO Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 23, 2024

NK:IO Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors grew 220% MoM, reaching 3.1K.

  • May 3, 2025

    Monthly visitors increased 133% MoM, reaching 2.3K.

NK:IO Filings

Explore SEC and related filing metadata, where available.

NK:IO filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NK:IO's valuation, stock price, and market status.

Is NK:IO a public or private company?

NK:IO is a private company.

What is the current stock price of NK:IO?

NK:IO is a private company with no public stock price. No recent secondary market data is available.

How much is NK:IO worth (valuation)?

Valuation information for NK:IO is not publicly available.

Can I buy NK:IO stock?

NK:IO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NK:IO's last funding round?

Funding round information for NK:IO is not publicly available.

Who are the main investors in NK:IO?

Investor information for NK:IO is not publicly disclosed.

Will NK:IO IPO soon?

No public IPO plans have been announced for NK:IO.

How can I track NK:IO secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NK:IO's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range8
Year Founded2020
Last FundingOct 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?